Recent studies have implicated CXCR7 overexpression with tumor aggressiveness and poor prognosis in a number of cancers, such as breast, prostate, and lung cancer (Iwakiri et al., 2009; Miao et al., 2007; Wang et al., 2008; Wani et al., 2014). Here, ACKR3 is linked to lung cancer.